Morgan Stanley (MS) Stock Forecast & Price Target

$163.78 +4.47 (+2.81%)

Closing price 10/24/2025 03:59 PM Eastern

Extended Trading

$163.93 +0.15 (+0.09%)

As of 10/24/2025 07:50 PM Eastern

Compare

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy

Based on 18 Analyst Ratings

Sell
0

Hold
9

Buy
9

Based on 18 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 9 have given a hold rating, 6 have given a buy rating, and 3 have given a strong buy rating for MS.

Consensus Price Target

$168.23
2.72% Upside

According to the 18 analysts' twelve-month price targets for Morgan Stanley, the average price target is $168.23. The highest price target for MS is $186.00, while the lowest price target for MS is $131.00. The average price target represents a forecasted upside of 2.72% from the current price of $163.78.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MS Analyst Ratings Over Time

Type	Current Forecast 10/25/24 to 10/25/25	1 Month Ago 9/25/24 to 9/25/25	3 Months Ago 7/27/24 to 7/27/25	1 Year Ago 10/26/23 to 10/25/24
Strong Buy	3 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	6 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	7 Buy rating(s)
Hold	9 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	10 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$168.23	$139.92	$138.25	$109.24
Forecasted Upside	2.72% Upside	-11.98% Downside	-3.32% Downside	-6.52% Downside
Consensus Rating	Moderate Buy	Hold	Hold	Hold

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Morgan Stanley Stock vs. The Competition

Type	Morgan Stanley	Finance Companies	S&P 500
Consensus Rating Score	2.67	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	2.72% Upside	41.99% Upside	12.09% Upside
News Sentiment Rating	Very Positive News See Recent MS News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/25/2025	Weiss Ratings 0 of 5 stars		Reiterated Rating	Buy (B-)
10/21/2025	Zacks Research 0 of 5 stars		Upgrade	Hold ➝ Strong-Buy
10/21/2025	JPMorgan Chase & Co. 2 of 5 stars	Kian Abouhossein Not Rated	Boost Target	Neutral	$122.00 ➝ $157.00	-3.01%
10/16/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$165.00 ➝ $177.00	+9.32%
10/16/2025	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Horowitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$155.00 ➝ $170.00	+5.00%
10/16/2025	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher McGratty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$176.00 ➝ $184.00	+12.40%
10/16/2025	Evercore ISI Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glenn Schorr Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$165.00 ➝ $175.00	+7.12%
10/16/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Fannon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$175.00 ➝ $186.00	+14.88%
10/16/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Goldberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$156.00 ➝ $183.00	+13.03%
10/7/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erika Najarian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$156.00 ➝ $165.00	+5.60%
Get the Latest News and Ratings for MS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Morgan Stanley and its competitors with MarketBeat's FREE daily newsletter.
10/3/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Ramsden Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$145.00 ➝ $164.00	+4.24%
10/3/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brennan Hawken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$180.00	+15.92%
10/1/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Sector Perform	$145.00 ➝ $171.00	+8.64%
5/24/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	H. Engel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
4/14/2025	JMP Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin Ryan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Perform
4/2/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Carrier Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$150.00 ➝ $144.00	+24.33%
11/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	S. Martinez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
11/26/2024	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold	$128.00 ➝ $131.00	-2.00%
7/17/2024	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform
4/16/2024	Cfra Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$97.00 ➝ $108.00	+20.82%
11/28/2023	Societe Generale Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold	$80.00	+2.63%
11/20/2023	BNP Paribas Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Outperform ➝ Neutral	$85.00	+5.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:01 PM ET.

Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, October 23, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

Here are some ways that investors could benefit from investing in Morgan Stanley:

The current stock price is around $158.70, which reflects a strong performance and potential for growth.
Recent earnings reports show that Morgan Stanley has exceeded analysts' expectations, with earnings per share significantly higher than consensus estimates, indicating robust financial health.
The company has initiated a substantial share buyback plan, allowing for the repurchase of up to $20 billion in shares, which often signals that management believes the stock is undervalued.
Analysts have recently upgraded their price targets for Morgan Stanley, with several firms giving it an "outperform" rating, suggesting positive market sentiment and potential for price appreciation.
The firm has a consistent dividend payout, with a recent quarterly dividend of $1.00, translating to an annualized yield of 2.5%, providing income to investors.

Morgan Stanley
Bear Case

Investors should be bearish about investing in Morgan Stanley for these reasons:

The company's high debt-to-equity ratio of 3.30 may raise concerns about financial leverage and risk, indicating that it relies heavily on borrowed funds.
Despite recent positive earnings, the stock has shown volatility, with a beta of 1.32, suggesting it may be more sensitive to market fluctuations compared to the overall market.
While the stock has a strong market cap of $253.34 billion, the current price-to-earnings ratio of 16.28 may indicate that the stock is fairly valued, limiting upside potential.
There are multiple analysts with a Hold rating on the stock, which may suggest a lack of strong conviction in its near-term performance.
The financial services sector can be influenced by economic downturns, and any adverse economic conditions could negatively impact Morgan Stanley's performance.

MS Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $168.23, with a high forecast of $186.00 and a low forecast of $131.00.
: 18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last year. There are currently 9 hold ratings, 6 buy ratings and 3 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MS shares.
: According to analysts, Morgan Stanley's stock has a predicted upside of 2.72% based on their 12-month stock forecasts.
: Over the previous 90 days, Morgan Stanley's stock had 2 upgrades by analysts.
: Morgan Stanley has been rated by research analysts at Barclays, BMO Capital Markets, Citigroup, Evercore ISI, Jefferies Financial Group, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Royal Bank Of Canada, The Goldman Sachs Group, UBS Group, Weiss Ratings, Wells Fargo & Company, and Zacks Research in the past 90 days.
: Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.
: Analysts like Morgan Stanley more than other "finance" companies. The consensus rating for Morgan Stanley is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MS) was last updated on 10/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Morgan Stanley (MS) Stock Forecast & Price Target